Marcus Dühren-von Minden
University of Freiburg
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marcus Dühren-von Minden.
Nature Immunology | 2015
Rudolf Übelhart; Eva Hug; Martina P. Bach; Thomas Wossning; Marcus Dühren-von Minden; Anselm H. C. Horn; Dimitrios Tsiantoulas; Kohei Kometani; Tomohiro Kurosaki; Christoph J. Binder; Heinrich Sticht; Lars Nitschke; Michael Reth; Hassan Jumaa
Mature B cells express immunoglobulin M (IgM)- and IgD-isotype B cell antigen receptors, but the importance of IgD for B cell function has been unclear. By using a cellular in vitro system and corresponding mouse models, we found that antigens with low valence activated IgM receptors but failed to trigger IgD signaling, whereas polyvalent antigens activated both receptor types. Investigations of the molecular mechanism showed that deletion of the IgD-specific hinge region rendered IgD responsive to monovalent antigen, whereas transferring the hinge to IgM resulted in responsiveness only to polyvalent antigen. Our data suggest that the increased IgD/IgM ratio on conventional B-2 cells is important for preferential immune responses to antigens in immune complexes, and that the increased IgM expression on B-1 cells is essential for B-1 cell homeostasis and function.
Nature Medicine | 2016
Seyedmehdi Shojaee; Lai N. Chan; Maike Buchner; Valeria Cazzaniga; Kadriye Nehir Cosgun; Huimin Geng; Yi Hua Qiu; Marcus Dühren-von Minden; Thomas Ernst; Andreas Hochhaus; Giovanni Cazzaniga; Ari Melnick; Steven M. Kornblau; Thomas G. Graeber; Hong Wu; Hassan Jumaa; Markus Müschen
Phosphatase and tensin homolog (PTEN) is a negative regulator of the phosphatidylinositol 3-kinase (PI3K) and protein kinase B (AKT) signaling pathway and a potent tumor suppressor in many types of cancer. To test a tumor suppressive role for PTEN in pre-B acute lymphoblastic leukemia (ALL), we induced Cre-mediated deletion of Pten in mouse models of pre-B ALL. In contrast to its role as a tumor suppressor in other cancers, loss of one or both alleles of Pten caused rapid cell death of pre-B ALL cells and was sufficient to clear transplant recipient mice of leukemia. Small-molecule inhibition of PTEN in human pre-B ALL cells resulted in hyperactivation of AKT, activation of the p53 tumor suppressor cell cycle checkpoint and cell death. Loss of PTEN function in pre-B ALL cells was functionally equivalent to acute activation of autoreactive pre–B cell receptor signaling, which engaged a deletional checkpoint for the removal of autoreactive B cells. We propose that targeted inhibition of PTEN and hyperactivation of AKT triggers a checkpoint for the elimination of autoreactive B cells and represents a new strategy to overcome drug resistance in human ALL.
Nature Communications | 2017
Claudia Minici; Maria Gounari; Rudolf Uebelhart; Lydia Scarfò; Marcus Dühren-von Minden; Dunja Schneider; Alpaslan Tasdogan; Alabbas Alkhatib; Andreas Agathangelidis; Stavroula Ntoufa; Nicholas Chiorazzi; Hassan Jumaa; Kostas Stamatopoulos; Paolo Ghia; Massimo Degano
Cell-autonomous B-cell receptor (BcR)-mediated signalling is a hallmark feature of the neoplastic B lymphocytes in chronic lymphocytic leukaemia (CLL). Here we elucidate the structural basis of autonomous activation of CLL B cells, showing that BcR immunoglobulins initiate intracellular signalling through homotypic interactions between epitopes that are specific for each subgroup of patients with homogeneous clinicobiological profiles. The molecular details of the BcR–BcR interactions apparently dictate the clinical course of disease, with stronger affinities and longer half-lives in indolent cases, and weaker, short-lived contacts mediating the aggressive ones. The diversity of homotypic BcR contacts leading to cell-autonomous signalling reconciles the existence of a shared pathogenic mechanism with the biological and clinical heterogeneity of CLL and offers opportunities for innovative treatment strategies.
British Journal of Haematology | 2016
Florian Scherer; Marlon van der Burgt; Szymon M. Kielbasa; Cristina Bertinetti-Lapatki; Marcus Dühren-von Minden; Kristina Mikesch; Katja Zirlik; Liesbeth de Wreede; Hendrik Veelken; Marcelo A. Navarrete
Cutts, B.A., Tran, H.A., Merriman, E., Nandurkar, D., Soo, G., DasGupta, D., Prassannan, N. & Hunt, B.J. (2014) The Utility of the Wells Clinical Prediction Model and Ventilation-Perfusion Scanning for Pulmonary Embolism in Pregnancy. Blood Coagulation and Fibrinolysis, 25, 375–378. DiPEP: Diagnosis of Pulmonary Embolism in Pregnancy ISRCTN21245595. Available at: http:// www.controlled-trials.com/ISRCTN21245595 (Accessed November 28, 2015) Goodacre, S., Nelson-Piercy, C., Hunt, B. & Chan, W.-S. (2015) When should we use diagnostic imaging to investigate for pulmonary embolism in pregnant and postpartum women? Emergency Medical Journal, 32, 78–82. Kline, J.A., Richardson, D.M., Than, M.P., Penaloza, A. & Roy, P.-M. (2014) Systematic Review and Meta-analysis of Pregnant Patients Investigated for Suspected Pulmonary Embolism in the Emergency Department. Academic Emergency Medicine, 21, 949–959. Ramsay, R., Byrd, L., Tower, C., James, J., Prescott, M. & Thachil, J. (2015) The problem of pulmonary embolism diagnosis in pregnancy. Brit J Haematol, 170, 727–736.
Nature Immunology | 2015
Rudolf Übelhart; Eva Hug; Martina P. Bach; Thomas Wossning; Marcus Dühren-von Minden; Anselm H. C. Horn; Dimitrios Tsiantoulas; Kohei Kometani; Tomohiro Kurosaki; Christoph J. Binder; Heinrich Sticht; Lars Nitschke; Michael Reth; Hassan Jumaa
Blood | 2015
Maria Gounari; Claudia Minici; Marcus Dühren-von Minden; Schneider Dunja; Alkhatib Alabbas; Übelhart Rudolf; Andreas Agathangelidis; Stavroula Ntoufa; Nicholas Chiorazzi; Hassan Jumaa; Kostas Stamatopoulos; Massimo Degano; Paolo Ghia
Blood | 2015
Marco Benkisser-Petersen; Maike Buchner; Arlette Dörffel; Marcus Dühren-von Minden; Kerstin Leberecht; Kathrin Kläsener; Rainer Claus; Ariane Ott; Christine Dierks; Hassan Jumaa; Fabio Malavasi; Michael Reth; Hendrik Veelken; Katja Zirlik
Blood | 2012
Marcus Dühren-von Minden; Thomas Wossning; Hassan Jumaa; Hendrik Veelken
F1000Research | 2010
Marcus Dühren-von Minden; Steven M. Kornblau; David B. Rosen; Aileen Cohen; Urte Gayko; Santosh Putta; John Woronicz; Wendy J. Fantl; Alessandra Cesano
F1000Research | 2010
Steven M. Kornblau; Marcus Dühren-von Minden; David B. Rosen; Santosh Putta; Aileen Cohen; Todd Covey; Wendy J. Fantl; Urte Gayko; Alessandra Cesano